((SL Advertiser)) Boston Scientific has prostate cancer solutions at Valley Urologic Associates. To learn more, go to ...

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Silk Road Medical, Inc. (Nasdaq: ...

Boston Scientific Corp. closed $1.60 below its 52-week high ($84.12), which the company achieved on September 13th.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TG Therapeutics (TGTX – Research Report) and Boston Scientific (BSX – Research Report) with bullish ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of California medical ...

Boston Scientific Corp. closed $0.61 short of its 52-week high ($84.12), which the company reached on September 13th.

The expanded indication includes conduction system pacing (CSP) and sensing of the left bundle branch area (LBBA) for use ...

Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $82.52 which represents a decrease of $-0.99 or -1.19% from the prior close of $83.51. The stock opened at $83.33 and touched ...

Investors have rewarded BSX stock thanks to the uptick in its sales for its new products and the Watchman line.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Boston Scientific (NYSE: BSX) received FDA approval to expand the indication for its current-generation Ingevity+ pacing ...

Boston Scientific (NYSE: BSX) announced today that it completed its $1.16 billion acquisition of Silk Road Medical ...